SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

BARONI, Marcello
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.983
EU - Europa 893
AS - Asia 415
OC - Oceania 9
SA - Sud America 7
Continente sconosciuto - Info sul continente non disponibili 3
Totale 4.310
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.972
CN - Cina 278
IT - Italia 261
DE - Germania 160
UA - Ucraina 154
GB - Regno Unito 96
TR - Turchia 96
PL - Polonia 63
SE - Svezia 56
FI - Finlandia 32
BE - Belgio 27
HK - Hong Kong 15
NL - Olanda 15
VN - Vietnam 14
AU - Australia 9
CA - Canada 9
RU - Federazione Russa 9
PE - Perù 6
RO - Romania 6
ES - Italia 4
FR - Francia 4
IR - Iran 3
JP - Giappone 3
EU - Europa 2
GE - Georgia 2
IE - Irlanda 2
IN - India 2
MX - Messico 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BR - Brasile 1
HU - Ungheria 1
IL - Israele 1
KR - Corea 1
MK - Macedonia 1
NO - Norvegia 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 4.310
Salva come PNG Salva come JPEG
Città #
Fairfield 383
Woodbridge 361
Chandler 274
Houston 206
Ann Arbor 190
Ashburn 178
Jacksonville 168
Seattle 162
Wilmington 150
Ferrara 140
Cambridge 123
Izmir 66
Warsaw 62
Nanjing 58
Princeton 56
Beijing 55
New York 46
Dearborn 37
Milan 37
Bremen 32
San Diego 31
Boardman 28
Shanghai 26
Falls Church 23
Brussels 22
Nanchang 22
Shenyang 22
Munich 17
Redwood City 16
Hebei 14
Hong Kong 14
Norwalk 14
Dong Ket 13
Jiaxing 12
Guangzhou 11
Mcallen 11
Florence 9
San Mateo 9
Tianjin 9
Verona 9
Los Angeles 8
Montréal 8
Auburn Hills 7
Des Moines 7
Zhengzhou 7
Abdullah 6
Augusta 6
Changsha 6
Jinan 5
Kunming 5
London 5
Monmouth Junction 5
Mountain View 5
Bologna 4
Leawood 4
Lima 4
Louvain 4
Rome 4
Washington 4
Castellarano 3
Cento 3
Chicago 3
Düsseldorf 3
Fuzhou 3
Haikou 3
Helsinki 3
Hounslow 3
Indiana 3
Lleida 3
Lusia 3
Palermo 3
Reading 3
Redmond 3
Taizhou 3
Wuhan 3
Albignasego 2
Ariano nel Polesine 2
Dronten 2
Hangzhou 2
Hefei 2
Imola 2
Kilburn 2
Lockport 2
Marienheide 2
Melbourne 2
Meppel 2
Minerbio 2
Orange 2
Pavia 2
Pucallpa 2
Quzhou 2
Russi 2
Taiyuan 2
Tokyo 2
Andover 1
Ardabil 1
Argelato 1
Bobenheim Am Berg 1
Bornem 1
Bratislava 1
Totale 3.312
Salva come PNG Salva come JPEG
Nome #
Activated factor VII-antithrombin complex predicts mortality in patients with stable coronary artery disease: a cohort study 147
Stimulation of P2 (P2X7) receptors in human dendritic cells induces the release of tissue factor-bearing microparticles. 145
Hemostasis biomarkers in multiple sclerosis 140
The carboxyl-terminal region is NOT essential for secreted and functional levels of coagulation factor X 138
Tissue factor and coagulation factor VII levels during acute myocardial infarction: association with genotype and adverse events. 134
Genetic determinants of activated factor VII antithrombin complex plasma concentration include tissue factor, factor VII and endothelial protein C receptor gene variants 127
Responsiveness of hemophilia B- causing non sense mutations to ribosome readthrough-inducing drugs strictly depends on the nucleotide and prrotein context 120
Changes in expression profiles of internal jugular vein wall and plasma protein levels in multiple sclerosis 119
Plasma levels of soluble NCAM in multiple sclerosis 117
Factor II Activity is Similarly Increased in Patients With Elevated Apolipoprotein CIII and in Carriers of the Factor II 20210A Allele 116
The carboxyl-terminal region is not essential for secreted and functional levels of coagulation factor X 114
Asymmetric processing of mutant factor X Arg386Cys reveals differences between intrinsic and extrinsic pathway activation 113
Membrane binding and anticoagulant properties of protein S natural variants 109
Molecular bases of type II protein S deficiency: the I203-D204 deletion in the EGF4 domain alters GLA domain function 105
Tissue Factor and Coagulation Factor VII Levels during Acute Myocardial Infarction Contribute to Predict Mortality and re-infarction. 105
Coagulation Factor XII Levels and Intrinsic Thrombin Generation in Multiple Sclerosis 99
Factor II Activity is Similarly Increased in Patients with Elevated Apolipoprotein CIII and in Carriers of the Factor II 20210A Allele 97
Impaired prothrombinase activity of factor X Gly381 Asp results in severe familial CRM+ FX deficiency 96
null 94
null 93
Increased CCL18 plasma levels are associated with neurodegenerative MRI outcomes in multiple sclerosis patients 90
Missense changes in the catalytic domain of coagulation factor X account for minimal function preventing a perinatal lethal condition 88
Non-conventional therapeutic strategies for inherited disorders oh hemostasis 87
Apolipoprotein C-III Strongly Correlates with Activated Factor VII-Anti-Thrombin Complex: An Additional Link between Plasma Lipids and Coagulation 87
Reduced activation of the Gla19Ala FX variant via the extrinsic coagulation pathway results in symptomatic CRMred FX deficiency 86
null 84
Expression profiles of the internal jugular and saphenous veins: Focus on hemostasis genes 84
Human protein S circulates in plasma partially bund to LDL and HDL: do PS-lipoprotein complexes mediate PS delivery within atherosclerotic plaque? 82
Release of Tissue Factor-bearing microparticles by human dendritic cells induced by stimulation of membrane P2X7 receptors 81
null 73
Activated factor VII: antithrombin complex plasma concentration in subjects with or without angiographically demonstrated coronary artery disease and myocardial infarction 73
TRATTAMENTO E PREVENZIONE DI MALATTIE CARDIOVASCOLARI CON ACIDO ERUCICO E METODI DIAGNOSTICI CORRELATI 69
THE NATURAL ARG386CYS MUTATION IN THE COAGULATION FACTOR X, AS A TOOL TO INVESTIGATE DIFFERENT FX-REQUIREMENTS IN INITIATION AND PROPAGATION PHASES. 68
Plasma levels of protein C pathway proteins and brain magnetic resonance imaging volumes in multiple sclerosis 68
Functional recovery in multiple sclerosis patients undergoing rehabilitation programs is associated with plasma levels of hemostasis inhibitors 68
Expression Profiles of the Internal Jugular and Saphenous Veins: Focus on Hemostasis Genes 66
The effect of the chemical chaperone 4-phenylbutyrate on secretion and activity of the p.Q160R missense variant of coagulation factor FVII 63
Natural mutations in the EGF4 domain of protein S produce extended conformational changes and alter phospholipid and C4bBP interactions 59
Molecular characterization of factor X deficiency associated with borderline plasma factor X level 57
null 56
Non-conventional therapeutic strategies for inherited disorders of hemostasis 53
Mutation-specific contributions to trace factor X levels account for a life-threating phenotype in a compound heterozygous factor X deficient patient 52
NATURAL MUTATIONS IN THE EGF4 DOMAIN OF PROTEIN S PRODUCE EXTENDED CONFORMATIONAL CHANGES AND ALTER PHOSPHOLIPID AND C4BBP INTERACTIONS 51
null 45
The F7 p.Val22Ile missense mutation affects splicing and can be counteracted by a compensatory U1snRNA 42
RNA-based therapeutic approaches for blood coagulation factor deficiencies caused by a splicing mutations 38
Hemostasis gene expression of the internal jugular and saphenous veins 36
Basophil Blood Cell Count Is Associated With Enhanced Factor II Plasma Coagulant Activity and Increased Risk of Mortality in Patients With Stable Coronary Artery Disease: Not Only Neutrophils as Prognostic Marker in Ischemic Heart Disease 36
Plasma levels of hemostasis inhibitors and MRI outcomes in multiple sclerosis (P3.368) 34
CCL18 plasma levels are increased in progressive MS patients and associated with MRI outcomes of tissue injury (P1.396) 33
The Factor VII Variant p.A354V-p.P464Hfs: Clinical versus Intracellular and Biochemical Phenotypes Induced by Chemical Chaperones 30
RNA−based therapeutic approaches for blood coagulation factor deficiencies caused by splicing mutations 25
Aptamer-modified FXa generation assays to investigate hypercoagulability in plasma from patients with ischemic heart disease 24
EFFECT OF SARS-CoV-2 ON THE COAGULATION CASCADE IN COVID-19 ASSOCIATED COAGULOPATHIES 18
In Situ Endothelial SARS-CoV-2 Presence and PROS1 Plasma Levels Alteration in SARS-CoV-2-Associated Coagulopathies 16
Combination of Genomic and Transcriptomic Approaches Highlights Vascular and Circadian Clock Components in Multiple Sclerosis 16
Protein S on the surface of plasma lipoproteins: a potential mechanism for protein S delivery to the atherosclerotic plaques? 13
Relationships among circulating levels of hemostasis inhibitors, chemokines, adhesion molecules, and mri characteristics in multiple sclerosis 12
Coagulation factor VII variants resistant to inhibitory antibodies. 11
Mapping of inhibitory antibodies directed to the carboxy-terminus of FVIIa in severe FVII deficiency with elongated C-terminal variant (p.A354V-p.P464Hfs†) 11
Suppression of “leaky” nonsense mutations by ribosome readthrough accounts for residual factor IX levels in Haemophilia B patients 9
Coagulation factor VII variants resistant to inhibitory antibodies 9
Crosstalk between hemostasis inhibitors and cholesterol biomarkers in multiple sclerosis 8
Immune response to treatment in a severe factor VII deficient patient: characterization of the inhibitory antibody and epitope-mapping 8
Natural Mutations in the 4th EGF-Like Domain of Protein S Alter GLA and SHBG Domain Interactions. 1
Treatment and prophylaxis of cardiovascular disorders with erucic acid and related diagnostic methods 1
Totale 4.449
Salva come PNG Salva come JPEG
Categoria #
all - tutte 16.956
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.956
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019308 0 0 0 0 0 0 0 0 0 0 116 192
2019/2020914 159 41 24 112 58 122 90 95 69 78 41 25
2020/2021820 47 42 27 97 25 58 81 80 50 145 123 45
2021/2022636 84 70 22 28 24 29 26 35 18 49 44 207
2022/2023634 60 64 23 87 92 88 46 50 67 8 37 12
2023/2024281 27 33 15 10 32 64 22 48 12 16 2 0
Totale 4.449